Biofrontera
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $6,988 | $9,030 | $8,588 | $12,559 |
Gross Profit | 5,066 | 6,650 | 5,513 | 7,287 |
EBITDA | -6,333 | -4,966 | -3,865 | -1,123 |
EBIT | -6,532 | -5,188 | -4,084 | -1,344 |
Net Income | -6,649 | -5,324 | -4,203 | -1,396 |
Net Change In Cash | 6,988 | 9,030 | 8,588 | 12,559 |
Free Cash Flow | -3,822 | -3,046 | -4,120 | -1,018 |
Cash | 3,417 | 7,239 | 1,785 | 5,905 |
Basic Shares | 10,776 | 9,351 | 5,516 | 5,516 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $37,303 | $34,071 | $28,674 | $24,100 |
Gross Profit | 18,696 | 16,627 | 13,489 | 11,358 |
EBITDA | -14,441 | -18,453 | 934 | -36,757 |
EBIT | -15,590 | -19,517 | -238 | -37,297 |
Net Income | -17,759 | -20,131 | -640 | -37,713 |
Net Change In Cash | 37,303 | 34,071 | 28,674 | 24,100 |
Free Cash Flow | -10,330 | -24,900 | -16,237 | -26,726 |
Cash | 5,905 | 1,343 | 17,208 | 24,545 |
Basic Shares | 5,516 | 1,546 | 1,056 | 855 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.62 |
2025-06-30 | -$0.57 |
2025-03-31 | -$0.50 |
2024-12-31 | -$0.23 |
